Theradaptive Wins Additional FDA Breakthrough Designation for Spinal Fusion
FREDERICK, Md. and BOSTON, Feb. 15, 2022 /PRNewswire/ -- Theradaptive, a privately held biopharmaceutical company pioneering a new class of regene...
United States Massachusetts Institute Of Technology Mark Shasti Prnewsfoto Theradaptive John Greenbaum Breakthrough Devices Program
Source: businessinsider.com